COPCOV trial

COPCOV study recruitment has resumed

This weekend the UK Medicines Healthcare Regulatory Agency has approved further enrolment into the COPCOV trial. We are beginning recruitment again this week and will be working hard to open sites across the UK during July.

Pause in recruitment

We received notice from the UK's MHRA (Medicines and Healthcare Products Regulatory Agency) to pause for now new enrolment into our COPCOV study. We responded promptly to the MHRA, addressing their concerns in detail and await their decision. For now, COPCOV study enrolment is paused around the globe. The safety of our participants is our first priority, as is preventing illness in front-line healthcare workers.

First UK COPCOV site news

First UK site confirms Capacity and Capability at Brighton and Sussex University Hospitals NHS Trust

UK approval given for COPCOV study

Approval given by the Health Research Authority and Care Research Wales for COPCOV to go ahead in England and Wales

First COPCOV participant enrolled

First participants enrolled into the COPCOV trial in Thailand. Further details here

COPCOV in the news

Article in Science Magazine highlights COPCOV to evaluate role of pre-exposure prophylaxis in protecting healthcare workers from COVID-19